China NMPA Drug Inspection - Jilin Huangzhihua Pharmaceutical Co., Ltd. - Zhuangjin Xugu Pills
China NMPA drug inspection for Jilin Huangzhihua Pharmaceutical Co., Ltd. published April 09, 2021. Drug: Zhuangjin Xugu Pills. On April 9, 2021, the Jiangsu Provincial Drug Administration released its first-quarter drug quality report for 2021, de
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jilin Huangzhihua Pharmaceutical Co., Ltd. published April 09, 2021. Drug: Zhuangjin Xugu Pills. On April 9, 2021, the Jiangsu Provincial Drug Administration released its first-quarter drug quality report for 2021, de
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox